A medication that stops Alzheimer's in its tracks?

Share this article:

Baxter BioScience's Gammagard halted the progression of Alzheimer's disease for as long as three years in a 16-patient trial. Results were presented at the Alzheimer's Association's annual meeting in Vancouver. The findings offer a “tantalizing” glimpse of the drug's potential, said William Thies, the association's chief medical and scientific officer.

A definitive study of 390 patients will be completed this year and released in early 2013, said Norman Relkin, the lead researcher, and the director of the Memory Disorders Program and a neurologist at New York Presbyterian/Weill Cornell Medical Center.

Share this article:
close

Next Article in Products

More in Products

Stents safe for stroke prevention, study says

Placing a stent to keep a neck artery open is as effective as invasive neck surgery for long-term prevention of strokes, according to results from a European trial.

Honeywell Introduces remote patient monitor

Honeywell Introduces remote patient monitor

Honeywell has launched the HomMed Genesis DM™ v4.15, a new version of the remote patient monitor with new peripheral devices.

NKF launches interactive nutrition portal

NKF launches interactive nutrition portal

The National Kidney Foundation has debuted My Food Coach, an interactive nutrition panel meant to allow people to easily manage nutritional requirements.